文献速递鼻科

全静脉麻醉与吸入麻醉用于内镜鼻窦手术:随机对照试验的荟萃分析

Total intravenous anaesthesia versus inhaled anaesthesia for endoscopic sinus surgery: a meta-analysis of randomized controlled trials.
PubMed 文献 · Rhinology · 2019-01-01

该荟萃分析纳入12项随机对照试验共560例患者,比较全静脉麻醉(TIVA)与吸入麻醉(IA)在内镜鼻窦手术中的效果。结果显示,与IA相比,TIVA可改善手术视野、减少估计失血量并缩短手术时间;亚组分析中,以瑞芬太尼为短效阿片类药物时上述获益存在,而以芬太尼时未见这些获益。

要点

  • 与吸入麻醉相比,全静脉麻醉可能改善内镜鼻窦手术的手术视野、减少估计失血量并缩短手术时间。
  • 亚组分析显示,以瑞芬太尼为短效阿片类药物时全静脉麻醉的获益存在,而以芬太尼时未见这些获益。
  • 瑞芬太尼是全静脉麻醉用于内镜鼻窦手术的首选短效阿片类药物。

核心结论

  • 与吸入麻醉相比,丙泊酚全静脉麻醉可能改善内镜鼻窦手术的手术视野质量、减少出血并缩短手术时间。
  • 瑞芬太尼是全静脉麻醉用于内镜鼻窦手术的首选短效阿片类药物。

研究设计与样本

  • 更新版荟萃分析,检索PubMed、EMBASE和Cochrane Library中比较全静脉麻醉与吸入麻醉的随机对照试验。
  • 共纳入12项随机对照试验,合计560例患者。
  • 两组术前特征相似。

主要发现

  • 与吸入麻醉相比,全静脉麻醉改善了手术视野、估计失血量和手术时间。
  • 以瑞芬太尼为短效阿片类药物的亚组分析中,全静脉麻醉改善了手术视野、估计失血量和手术时间。
  • 以芬太尼为短效阿片类药物时未见到这些获益。

临床怎么用

  • 作者认为,与吸入麻醉相比,丙泊酚全静脉麻醉可能改善内镜鼻窦手术的手术视野质量、减少出血并缩短手术时间。
  • 作者认为,瑞芬太尼是全静脉麻醉用于内镜鼻窦手术的首选短效阿片类药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total intravenous anaesthesia (TIVA) with propofol, compared to inhaled anaesthesia (IA), has been proposed to reduce bleeding and improve surgical field quality during endoscopic sinus surgery (ESS), but prior meta-analyses have not been conclusive. We performed an updated meta-analysis to determine the benefit of TIVA versus IA during ESS. METHODOLOGY: PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCTs) comparing TIVA versus IA. Demographic and outcome data were extracted from articles meeting selection criteria and analysed. RESULTS: We included 12 RCTs for a total of 560 patients. Preoperative characteristics were similar between the two groups. Compared to IA, TIVA improved surgical visibility, estimated blood loss (EBL), and operative time. In a subgroup analysis with remifentanil as the short-acting opioid, TIVA improved surgical visibility, EBL, and operative time. These benefits were not seen with fentanyl as the short-acting opioid. CONCLUSIONS: TIVA with propofol, in comparison to IA, may improve surgical field quality, reduce blood loss, and decrease operative time for ESS. Remifentanil is the preferred short-acting opioid for TIVA in ESS.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Kolia NR, Man LX. Total intravenous anaesthesia versus inhaled anaesthesia for endoscopic sinus surgery: a meta-analysis of randomized controlled trials. Rhinology. 2019. PMID: 31329812. doi:10.4193/Rhin19.171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。